Agrawal Alok K.
Known title: Chief Strategy OfficerCIK: 0001973227
Associated companies
Transaction History
| CLS | ▲ Buy | Option Exercise | 14,178 | $0 | 2/5/2025 | View on chart |
| CLS | ▼ Sell | Tax Withholding | 7,352 | $985K | 2/5/2025 | View on chart |
| CLS | ▼ Sell | Open Market | 6,826 | $914K | 2/5/2025 | View on chart |
| CLS | ▼ Sell | Open Market | 14,634 | $1.8M | 2/3/2025 | View on chart |
| CLS | ▲ Buy | Option Exercise | 1,477 | $0 | 2/2/2025 | View on chart |
| CLS | ▼ Sell | Tax Withholding | 766 | $95K | 2/2/2025 | View on chart |
| CLS | ▲ Buy | Option Exercise | 28,916 | $0 | 2/1/2025 | View on chart |
| CLS | ▼ Sell | Tax Withholding | 14,993 | $1.9M | 2/1/2025 | View on chart |
| CLS | ▼ Sell | Tax Withholding | 1,900 | $242K | 1/31/2025 | View on chart |
| CLS | ▼ Sell | Open Market | 1,763 | $225K | 1/31/2025 | View on chart |
| CLS | ▲ Buy | Option Exercise | 3,663 | $0 | 1/31/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Celestica noted in recent analyst optimism and stock picks
Recent media coverage has placed Celestica in several analyst and stock‑selection pieces. One article notes that Wall Street analysts hold an optimistic outlook, reflected in an average price target of $473.91. Another comparison with SpaceX highlights Celestica’s position in the aerospace sector. The stock is currently trading near a long‑standing support level, with momentum indicators showing modest weakness.
Celestica noted in recent analyst optimism and stock picks. Recent media coverage has placed Celestica in several analyst and stock‑selection pieces. One article notes that Wall Street analysts hold an optimistic outlook, reflected in an average price target of $473.91. Another comparison with SpaceX highlights Celestica’s position in the aerospace sector. The stock is currently trading near a long‑standing support level, with momentum indicators showing modest weakness.